Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass

被引:100
|
作者
Dekker, N. A. M. [1 ,2 ,3 ]
Veerhoek, D. [1 ,2 ,3 ]
Koning, N. J. [1 ,2 ,3 ]
van Leeuwen, A. L. I. [1 ,2 ,3 ]
Elbers, P. W. G. [6 ]
van den Brom, C. E. [1 ,2 ,3 ]
Vonk, A. B. A. [4 ]
Boer, C. [5 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Expt Lab,Dept Anaesthesiol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Expt Lab,Dept Physiol, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Expt Lab,Dept Cardiothorac Surg, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Dept Cardiothorac Surg, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam UMC, Dept Anaesthesiol, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Dept Intens Care Med, Res VUmc Intens Care REVIVE, Amsterdam UMC,Amsterdam Infect & Immun Inst, Amsterdam, Netherlands
关键词
blood oxygen transport; oxygen delivery to tissues; factors impacting; cardiopulmonary bypass management; endothelial glycocalyx; microcirculation; VASCULAR LEAKAGE; RAT MODEL; ON-PUMP; FLOW; TRANSFUSION; PULSATILE; DAMAGE; HEMODILUTION; OXYGENATION; DYSFUNCTION;
D O I
10.1111/anae.14577
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We investigated microcirculatory perfusion disturbances following cardiopulmonary bypass in the early postoperative period and whether the course of these disturbances mirrored restoration of endothelial glycocalyx integrity. We performed sublingual sidestream dark field imaging of the microcirculation during the first three postoperative days in patients who had undergone on-pump coronary artery bypass graft surgery. We calculated the perfused vessel density, proportion of perfused vessels and perfused boundary region. Plasma was obtained to measure heparan sulphate and syndecan-1 levels as glycocalyx shedding markers. We recruited 17 patients; the mean (SD) duration of non-pulsatile cardiopulmonary bypass was 103 (18) min, following which 491 (29) ml autologous blood was transfused through cell salvage. Cardiopulmonary bypass immediately decreased both microcirculatory perfused vessel density; 11 (3) vs. 16 (4) mm.mm(-2), p = 0.052 and the proportion of perfused vessels; 92 (5) vs. 69 (9) %, p < 0.0001. The proportion of perfused vessels did not increase after transfusion of autologous salvaged blood following cardiopulmonary bypass; 72 (7) %, p = 0.19 or during the first three postoperative days; 71 (5) %, p < 0.0001. The perfused boundary region increased after cardiopulmonary bypass; 2.2 (0.3) vs. 1.9 (0.3) mu m, p = 0.037 and during the first three postoperative days; 2.4 (0.3) vs. 1.9 (0.3) mu m, p = 0.003. Increased plasma heparan sulphate levels were inversely associated with the proportion of perfused vessels during cardiopulmonary bypass; R = -0.49, p = 0.02. Plasma syndecan-1 levels were inversely associated with the proportion of perfused vessels during the entire study period; R = -0.51, p < 0.0001. Our study shows that cardiopulmonary bypass-induced acute microcirculatory perfusion disturbances persist in the first three postoperative days, and are associated with prolonged endothelial glycocalyx shedding. This suggests prolonged impairment and delayed recovery of both microcirculatory perfusion and function after on-pump cardiac surgery.
引用
收藏
页码:609 / 618
页数:10
相关论文
共 50 条
  • [31] Early platelet recovery following cardiac surgery with cardiopulmonary bypass
    Van Poucke, Sven
    Stevens, Kris
    Wetzels, Rick
    Kicken, Cecile
    Verhezen, Paul
    Theunissen, Maurice
    Kuiper, Gerhardus
    van Oerle, Rene
    Henskens, Yvonne
    Lance, Marcus
    PLATELETS, 2016, 27 (08) : 751 - 757
  • [32] DURATION OF CARDIOPULMONARY BYPASS IN PEDIATRIC CARDIAC SURGERY IS NOT ASSOCIATED WITH POSTOPERATIVE INFECTIONS
    Algra, S. O.
    Driessen, M. M. P.
    Schadenberg, A. W. L.
    Schouten, A. N. J.
    Haas, F.
    Bollen, C. W.
    Jansen, N. J. G.
    PEDIATRIC RESEARCH, 2010, 68 : 682 - 682
  • [33] Postoperative infection after cardiac surgery under cardiopulmonary bypass.
    Mazzucotelli, JP
    Benkelfat, C
    Saal, JP
    Pouillart, F
    Mazri, F
    Barillà, A
    Le Houérou, D
    Perron, D
    Palsky, E
    Romano, M
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1999, 92 (12): : 1719 - 1726
  • [34] Postoperative neurological complications in patients undergoing cardiac surgery with cardiopulmonary bypass
    More Duarte, Alain
    Fuentes Herrera, Leonel
    Ceballos Alvarez, Alina
    Rodriguez Gonzalez, Leyslett
    Plasencia Perez, Mario
    Zorrilla Linares, Yurien
    Robaina Cabrera, Edixon
    Zamora Roche, Ortelio
    CORSALUD, 2015, 7 (01): : 28 - 34
  • [35] Cardiopulmonary bypass in cardiac surgery
    Baehner, T.
    Boehm, O.
    Probst, C.
    Poetzsch, B.
    Hoeft, A.
    Baumgarten, G.
    Knuefermann, P.
    ANAESTHESIST, 2012, 61 (10): : 846 - 856
  • [36] Functionally-active endothelial progenitor cells are mobilised following cardiac surgery with or without cardiopulmonary bypass
    Roberts, N.
    Xiao, Q.
    Weir, G.
    Xu, Q.
    Jahangiri, M.
    HEART, 2007, 93 (02)
  • [37] The combined effects of the microcirculatory status and cardiopulmonary bypass on platelet count and function during cardiac surgery
    Di Dedda, Umberto
    Ranucci, Marco
    Porta, Alberto
    Bari, Vlasta
    Ascari, Alice
    Fantinato, Angela
    Baryshnikova, Ekaterina
    Cotza, Mauro
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2018, 70 (03) : 327 - 337
  • [38] Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion
    Chappell, Daniel
    Jacob, Matthias
    Hofmann-Kiefer, Klaus
    Rehm, Markus
    Welsch, Ulrich
    Conzen, Peter
    Becker, Bernhard F.
    CARDIOVASCULAR RESEARCH, 2009, 83 (02) : 388 - 396
  • [39] Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
    Warltier, DC
    Nijhawan, N
    Montgomery, MW
    Nicolosi, AC
    Pagel, PS
    XIII WORLD CONGRESS OF CARDIOLOGY: FREE PAPERS, 1998, : 1015 - 1018
  • [40] Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
    E-P Sandell
    N Nijhawan
    PS Pagel
    DC Warltier
    Critical Care, 6 (Suppl 1):